ASHLEY WEILER: Open Payments
NPI 1861177966 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,787 in 50 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $535 · 2025 $2,787
Food & beverage: $2,707Education: $80
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $518 |
| UCB, Inc. | 5 | $481 |
| Galderma Laboratories, L.P. | 9 | $376 |
| ABBVIE INC. | 10 | $330 |
| LEO Pharma Inc. | 3 | $263 |
| Amgen Inc. | 4 | $252 |
| Incyte Corporation | 1 | $123 |
| Lilly USA, LLC | 1 | $119 |
| PFIZER INC. | 1 | $105 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
Products named: DUPIXENT, Bimzelx, NEMLUVIO, SKYRIZI, OTEZLA, ADBRY, Opzelura, ANZUPGO.
Industry payments across AZ — which companies pay providers there.
